{
  "id": "mhgap#screening_cues_d3c886be",
  "content": "imipramine, aripiprazole plus citalopram, sertraline y Acquisition costs can differ substantially and also\nplus lithium, bupropion, citalopram and risperidone throughout the world.\nplus paroxetine were not convincingly different than y Lithium carbonate, sodium valproate (valproic\nplacebo. However, sertraline was also close to being acid), carbamazepine and quetiapine (therapeutic\npossibly superior to placebo. alternatives: aripiprazole, olanzapine, paliperidone)\ny Overall, data suggest that antidepressants (alone) are available in the WHO EML (13).\nmay be efficacious with small effects, but it is y Antidepressant treatment should begin at a low\nunclear if they differ. dose and be increased gradually if necessary.\ny For the outcome “manic switch”, all investigated y Individuals should be monitored carefully for\nmedicines were not convincingly different than early signs of manic symptoms. Antidepressants\nplacebo. However, these data were mainly from should be stopped soon after remission of\nshort-term studies. Generally, manic switch seems to depressive symptoms, while mood stabilizer should\nbe a rare complication. be continued.\n100\n3. Recommendations\nPSY10. In adults with psychotic disorders (including schizophrenia),\nare psychological interventions (such as psychoeducation,\nfamily interventions and cognitive behavioural therapy)\neffective in the acute phase?\nRecommendation (update): Treatment based on cognitive behavioural therapy (CBT) should be",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "screening_cues",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues imipramine, aripiprazole plus citalopram, sertraline y Acquisition costs can differ substantially and also\nplus lithium, bupropion, citalopram and risperidone throughout the world.\nplus paroxetine were not convincingly different than y Lithium carbonate, sodium valproate (valproic\nplacebo. However, sertraline was also close to being acid), carbamazepine and quetiapine (therapeutic\npossibly superior to placebo. alternatives: aripiprazole, olanzapine, paliperidone)\ny Overall, data suggest that antidepressants (alone) are available in the WHO EML (13).\nmay be efficacious with small effects, but it is y Antidepressant treatment should begin at a low\nunclear if they differ. dose and be increased gradually if necessary.\ny For the outcome “manic switch”, all investigated y Individuals should be monitored carefully for\nmedicines were not convincingly different than early signs of manic symptoms. Antidepressants\nplacebo. However, these data were mainly from should be stopped soon after remission of\nshort-term studies. Generally, manic switch seems to depressive symptoms, while mood stabilizer should\nbe a rare complication. be continued.\n100\n3. Recommendations\nPSY10. In adults with psychotic disorders (including schizophrenia),\nare psychological interventions (such as psychoeducation,\nfamily interventions and cognitive behavioural therapy)\neffective in the acute phase?\nRecommendation (update): Treatment based on cognitive behavioural therapy (CBT) should be Imipramine, aripiprazole plus citalopram, sertraline y acquisition costs can differ substantially and also\nplus lithium, bupropion, citalopram and risperidone throughout the world. plus paroxetine were not convincingly d..."
}